Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
JAAPA ; 33(10): 21-28, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32941305

ABSTRACT

Sickle cell disease (SCD) is a group of disorders affecting the hemoglobin in erythrocytes. SCD is associated with significant morbidity and mortality and occurs most commonly among people of African ancestry. In 2014, the National Heart, Lung, and Blood Institute updated its guidelines for the management of SCD. These guidelines were implemented to provide evidence-based recommendations to assist primary care clinicians in the proper management of patients with SCD. This article reviews the current practice guidelines for SCD, with attention to health maintenance and hydroxyurea.


Subject(s)
Anemia, Sickle Cell/diagnosis , Anemia, Sickle Cell/therapy , Antisickling Agents/administration & dosage , Hydroxyurea/administration & dosage , Primary Health Care , Administration, Oral , Anemia, Sickle Cell/epidemiology , Anemia, Sickle Cell/etiology , Antibodies, Monoclonal, Humanized/administration & dosage , Blood Transfusion , Evidence-Based Medicine , Female , Glutamine/administration & dosage , Hematopoietic Stem Cell Transplantation , Humans , Hydroxyurea/adverse effects , Hydroxyurea/pharmacology , Iodine Isotopes/administration & dosage , Maintenance Chemotherapy , Male , Monitoring, Physiologic , Practice Guidelines as Topic
SELECTION OF CITATIONS
SEARCH DETAIL